...
Product Theater – Amgen: Managing Continued Treatment for Chronic Moderate to Severe Plaque Psoriasis
November 21, 2019

Faculty: Paul Yamauchi, MD, PhD Dr. Yamauchi reviewed the long term use of Enbrel (etanercept) for the treatment of moderate to severe plaque psoriasis. Psoriasis is an immune mediated disease characterized by erythematous scaling plaques and patches. Enbrel is a treatment for patients ages 4 and older who are candidates for systemic therapy or phototherapy …

...
Do Biologic Therapies Affect the Elderly Differently?
September 12, 2018

Treating psoriasis with a systemic biologic therapy is increasingly the standard course of treatment, but little is known about how these therapies affect the elderly. Elderly patients are frequently excluded from biological clinical trials and simply described as a high-risk group for adverse events. This has led to a lack of information about safety and …